Clinical trial
Interleukin-2 in Treating Patients With Stage III or Stage IV Kidney Cancer That…
NCT00003604 · Cancer Biotherapy Research Group, Other · Unknown status
Key facts
| NCT number | NCT00003604 |
|---|---|
| Title | Interleukin-2 in Treating Patients With Stage III or Stage IV Kidney Cancer That Has Been Removed With Surgery |
| Official title | A Multi-Center Adjuvant Trial of Outpatient Moderate-Dose Bolus Interleukin-2 for Renal Cancer |
| Lead sponsor | Cancer Biotherapy Research Group, Other |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Kidney Cancer |
| Intervention type | Biological |
| Interventions | aldesleukin |
| Enrollment | 20 |
| Start date | Oct 1, 1997 |
| First posted | Jul 16, 2004 |
| Last update posted | Nov 6, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: